VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
KYTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
KYTXKyverna Therapeutics, Inc.
$4.70$286M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksKYTXQuarterly Financials

Kyverna Therapeutics, Inc. (KYTX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Kyverna Therapeutics, Inc. (KYTX) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

KYTX Income Statement

Quarterly statement

KYTX Income Statement

Kyverna Therapeutics, Inc. (KYTX) annual income statement — 5-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue00000000000000
Revenue Growth %--------------
Cost of Goods Sold00351K00515K501K563K29.19M022.48K17.16M00
COGS % of Revenue--------------
Gross Profit00-351K00-515K-501K-563K-29.19M0-22.48K-17.16M00
Gross Margin %--------------
Gross Profit Growth %-100%29.94%100%100%--2129.04%96.72%------
Operating Expenses42.9M39.56M41.02M39.28M38.73M43.9M46.91M40.48M9.58M33.44M6.88K4.21M16.28M13.3M
OpEx % of Revenue--------------
Selling, General & Admin15.88M14.77M11.29M9.27M8.27M8.59M9.97M7.56M7.88M6.11M5.78K4.21M2.64M2.9M
SG&A % of Revenue--------------
Research & Development27.02M24.79M29.72M30.01M30.46M35.82M37.43M32.92M29.19M27.32M22.48K17.16M13.64M10.4M
R&D % of Revenue--------------
Other Operating Expenses00000-515K-501K0-1000K0-21.38K-1000K00
Operating Income-42.9M-39.56M-41.37M-39.28M-38.73M-44.41M-47.41M-41.04M-38.77M-33.44M-29.36K-21.38M-16.28M-13.3M
Operating Margin %--------------
Operating Income Growth %-10.77%10.93%12.74%4.29%0.11%-32.82%--91.99%-138.12%-151.35%----
EBITDA-42.63M-39.12M-41.02M-38.91M-38.31M-43.9M-46.91M-40.48M-38.21M-32.91M452.64K-21.15M-15.84M-12.89M
EBITDA Margin %--------------
EBITDA Growth %-11.26%10.87%12.56%3.86%-0.26%-33.4%-10462.94%-91.42%-141.18%-155.3%----
D&A (Non-Cash Add-back)274K434K351K368K415K515K501K563K558K530K482K231K438K413K
EBIT-41.21M-37.65M-39.06M-37.36M-36.78M-42.07M-44.61M-37.46M-37.07M-28.76M-28.26K-21.38M-15.41M-13.04M
Net Interest Income952K1.25M1.66M1.46M1.99M2.35M2.8M3.55M4.32M4.66M2.69M742K830K218K
Interest Income1.68M1.93M2.33M1.91M2M2.36M2.83M3.58M4.36M4.69M2.73M789K880K264K
Interest Expense728K674K667K444K7K14K25K27K32K39K44K47K50K46K
Other Income/Expense958K1.24M1.64M1.48M1.94M2.33M2.77M3.55M4.28M4.63M2.67K710K817K211K
Pretax Income-41.94M-38.32M-39.73M-37.8M-36.79M-42.08M-44.63M-37.49M-34.49M-28.8M-26.69K-20.67M-15.46M-13.09M
Pretax Margin %--------------
Income Tax00000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-41.94M-38.32M-39.73M-37.8M-36.79M-42.08M-44.63M-37.49M-34.49M-28.8M-26.69K-20.67M-15.46M-13.09M
Net Margin %--------------
Net Income Growth %-14.01%8.94%10.99%-0.84%-6.65%-46.1%--81.4%-123.03%-120.02%----
Net Income (Continuing)-41.94M-38.32M-39.73M-37.8M-36.79M-42.08M-44.63M-37.49M-34.49M-28.8M-26.69K-20.67M-15.46M-13.09M
Discontinued Operations00000000000000
Minority Interest00000000000000
EPS (Diluted)-0.68-0.63-0.66-0.80-0.85-0.97-1.03-0.87-0.80-0.67-1.12-0.48-0.36-0.30
EPS Growth %20%35.05%35.92%8.05%-6.25%-44.78%8.04%-81.25%-122.22%-123.33%----
EPS (Basic)-0.68-0.63-0.66-0.80-0.85-0.97-1.03-0.87-0.80-0.67-1.12-0.48-0.36-0.30
Diluted Shares Outstanding61.96M60.9M60.43M47.16M43.42M43.23M43.22M43.21M43.17M43.15M23.75M43.12M43.12M43.12M
Basic Shares Outstanding61.96M60.9M60.43M47.16M43.42M43.23M43.22M43.21M43.17M43.15M23.75M43.12M43.12M43.12M
Dividend Payout Ratio--------------